Novartis Sues Alvogen to Block Generic Dementia Patch

Novartis AG slapped generic-drug maker Alvogen Group with a lawsuit in Delaware, accusing Alvogen of infringing two patents by seeking U.S. regulatory approval to make and sell generic versions of the Exelon patch, a dementia treatment.
Law360